Get started Log in

CMB — Cambium Bio Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Market Cap
AU$12.30m
Enterprise Value
AU$11.33m
Revenue
AU$0.64m

Brief: Cambium Bio Says Raised A$3.48 Million In Strategic Placement
05/04/2024 05:06
Brief: Regeneus Says Regeneus Secures Shareholder Approval For Merger
28/03/2024 08:14
Brief: Regeneus Enters Binding Merger Agreement With Cambium Medical Technologies
14/02/2024 09:13
Brief: Regeneus Agrees To Merge With Cambium Medical Technologies
28/04/2023 24:56
Brief: Regeneus Says To Settle A$2.0 Mln Outstanding Loan & Interest With Paddington St Finance
28/02/2023 01:23
Brief: Regeneus Says Received Notice Of Termination From Kyocera
31/01/2023 08:51
Brief: Regeneus Seeks Trading Halt
29/01/2023 22:33
Brief: Regeneus Says FY Net Loss For Year Attributable A$4.3 Mln
30/08/2022 06:50
Brief: Regeneus Secures Non-Dilutive A$4.0M Loan Financing Against Kyocera's Upcoming Us$3.0M Milestone Payment
29/04/2022 02:38
Notification of cessation of securities - RGS
08/03/2022 04:46
Final Director's Interest Notice
04/03/2022 24:00
Director Appointment/Resignation
01/03/2022 23:09
Brief: Regeneus Ltd Says HY Revenue From Ordinary Activities A$20,005 Versus A$7.1 Million
25/02/2022 04:26
PRE_NR Ends: 15:31:38
25/02/2022 04:20
Half Yearly Report and Accounts
25/02/2022 04:20
PRE_NR Ends: 10:48:22
24/02/2022 23:37
Grant of ASX Waiver
24/02/2022 23:37
Notification of cessation of securities - RGS
04/02/2022 06:05
Lapse of Unlisted Share Options
04/02/2022 24:00
Quarterly Activities/Appendix 4C Cash Flow Report
28/01/2022 05:14